About Psychemedics (NASDAQ:PMD)
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.
Industry, Sector and Symbol
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:PMD
CUSIPN/A
Phone978-206-8220
Debt
Debt-to-Equity Ratio0.13%
Current Ratio3.28%
Quick Ratio3.28%
Price-To-Earnings
Trailing P/E Ratio22.94
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$39.70 million
Price / Sales2.95
Cash Flow$1.5627 per share
Price / Cash13.63
Book Value$3.39 per share
Price / Book6.28
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$6.12 million
Net Margins15.42%
Return on Equity29.23%
Return on Assets19.83%
Miscellaneous
Employees231
Outstanding Shares5,490,000
Psychemedics (NASDAQ:PMD) Frequently Asked Questions
What is Psychemedics' stock symbol?
Psychemedics trades on the NASDAQ under the ticker symbol "PMD."
How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?
Psychemedics announced a quarterly dividend on Wednesday, March 7th. Stockholders of record on Monday, March 19th will be given a dividend of $0.15 per share on Thursday, March 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date is Friday, March 16th. View Psychemedics' Dividend History.
How were Psychemedics' earnings last quarter?
Psychemedics Co. (NASDAQ:PMD) issued its earnings results on Wednesday, March, 7th. The company reported $0.22 earnings per share for the quarter. The firm had revenue of $9.76 million for the quarter. Psychemedics had a net margin of 15.42% and a return on equity of 29.23%. View Psychemedics' Earnings History.
When is Psychemedics' next earnings date?
Who are some of Psychemedics' key competitors?
Some companies that are related to Psychemedics include Invitae (NVTA), Enzo Biochem (ENZ), CareDx (CDNA), Veracyte (VCYT), Miragen Therapeutics (MGEN), Celcuity (CELC), Fulgent Genetics (FLGT), First Choice Healthcare Solutions (FCHS), Cancer Genetics (CGIX), Biocept (BIOC), OpGen (OPGN), Cord Blood America (CBAI) and PotNetwork (POTN).
Who are Psychemedics' key executives?
Psychemedics' management team includes the folowing people:
- Mr. Raymond C. Kubacki Jr., Chairman, Chief Exec. Officer and Pres (Age 73)
- Mr. James V. Dyke, Corp. VP of Sales & Marketing (Age 53)
- Dr. Michael I. Schaffer Ph.D., VP of Laboratory Operations (Age 73)
- Dr. Werner A. Baumgartner Ph.D., Founder
- Ms. Annette Baumgartner, Founder
Has Psychemedics been receiving favorable news coverage?
News stories about PMD stock have trended somewhat positive on Wednesday, according to Accern Sentiment. The research group scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Psychemedics earned a daily sentiment score of 0.01 on Accern's scale. They also assigned headlines about the company an impact score of 45.02 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Psychemedics?
Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Psychemedics' stock price today?
One share of PMD stock can currently be purchased for approximately $21.30.
How big of a company is Psychemedics?
Psychemedics has a market capitalization of $113.41 million and generates $39.70 million in revenue each year. Psychemedics employs 231 workers across the globe.
How can I contact Psychemedics?
Psychemedics' mailing address is 289 GREAT ROAD, ACTON MA, 01720. The company can be reached via phone at 978-206-8220.
MarketBeat Community Rating for Psychemedics (PMD)
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe PMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
Psychemedics (NASDAQ:PMD) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/25/2016 forward)
Psychemedics (NASDAQ:PMD) Earnings History and Estimates Chart
Psychemedics (NASDAQ PMD) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/1/2018 | | | | | | | | |
| 4/24/2018 | Q1 2018 | | $0.23 | | $10.94 million | View | N/A |  |
| 3/7/2018 | Q4 2017 | | $0.22 | | $9.76 million | View | N/A | |
| 10/24/2017 | Q3 2017 | | $0.25 | | $10.05 million | View | N/A | |
| 8/2/2017 | Q2 2017 | | $0.16 | | $9.68 million | View | N/A | |
| 4/25/2017 | Q1 2017 | | $0.27 | | $10.21 million | View | N/A | |
| 2/6/2017 | Q4 2016 | | $0.43 | | $10.76 million | View | N/A | |
| 10/26/2016 | Q3 2016 | | $0.49 | | $11.85 million | View | N/A | |
| 7/26/2016 | Q2 2016 | | $0.30 | | $9.70 million | View | N/A | |
| 2/10/2016 | Q4 2015 | | $0.03 | | $6.13 million | View | N/A | |
| 10/28/2015 | Q3 2015 | | $0.15 | | $7.08 million | View | N/A | |
| 7/28/2015 | Q2 2015 | | $0.05 | | $7.00 million | View | N/A | |
| 4/27/2015 | Q1 2015 | | $0.05 | | $6.76 million | View | N/A | |
| 2/10/2015 | Q414 | $0.08 | $0.13 | | $6.80 million | View | N/A | |
| 10/30/2014 | Q3 2014 | | $0.17 | | $7.70 million | View | N/A | |
| 7/28/2014 | | $0.03 | $0.16 | | $7.69 million | View | N/A | |
| 4/29/2014 | Q114 | $0.12 | $0.14 | $6.40 million | $7.00 million | View | N/A | |
| 2/10/2014 | Q4 | | $0.16 | | $6.48 million | View | N/A | |
| 10/28/2013 | Q313 | | $0.20 | | $7.06 million | View | N/A | |
| 8/5/2013 | Q2 2013 | | $0.20 | | $6.90 million | View | N/A | |
| 5/7/2013 | Q1 2013 | | $0.16 | | $6.43 million | View | N/A | |
| 2/25/2013 | Q4 2012 | | $0.05 | $5.55 million | $5.66 million | View | N/A | |
| 11/5/2012 | Q3 2012 | | $0.17 | | | View | N/A | |
| 8/7/2012 | Q2 2012 | | $0.19 | | | View | N/A | |
| 5/8/2012 | Q1 2012 | | $0.16 | | | View | N/A | |
| 2/23/2012 | Q4 2011 | | $0.08 | | | View | N/A | |
| 11/3/2011 | Q3 2011 | $0.19 | $0.21 | | | View | N/A | |
| 8/10/2011 | Q2 2011 | | $0.21 | | | View | N/A | |
| 5/5/2011 | Q1 2011 | $0.10 | $0.16 | | | View | N/A | |
| 3/2/2011 | Q4 2010 | | $0.08 | | | View | N/A | |
| 11/4/2010 | Q3 2010 | $0.12 | $0.16 | | | View | N/A | |
| 8/10/2010 | Q2 2010 | $0.10 | $0.17 | | | View | N/A | |
| 5/11/2010 | Q1 2010 | $0.06 | $0.10 | | | View | N/A | |
| 2/23/2010 | Q4 2009 | | $0.10 | | | View | N/A | |
| 11/3/2009 | Q3 2009 | | $0.15 | | | View | N/A | |
| 8/4/2009 | Q2 2009 | | $0.03 | | | View | N/A | |
| 5/7/2009 | Q1 2009 | | $0.01 | | | View | N/A | |
| 2/18/2009 | Q4 2008 | | $0.03 | | | View | N/A | |
| 11/3/2008 | Q3 2008 | | $0.17 | | | View | N/A | |
| 7/28/2008 | Q2 2008 | | $0.20 | | | View | N/A | |
| 4/30/2008 | Q1 2008 | | $0.17 | | | View | N/A | |
| 2/14/2008 | Q4 2007 | | $0.17 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Psychemedics (NASDAQ:PMD) Dividend Information
Psychemedics pays an annual dividend of $0.60 per share, with a dividend yield of 2.82%. PMD's most recent quarterly dividend payment was Thursday, March 29.
| Most Recent Dividend: | 3/29/2018 |
| Annual Dividend: | $0.60 |
| Dividend Yield: | 2.82% |
| Payout Ratio: | N/A |
Psychemedics (NASDAQ:PMD) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 3/7/2018 | Quarterly | $0.15 | | 3/16/2018 | 3/19/2018 | 3/29/2018 |
| 10/25/2017 | quarterly | $0.15 | 3.48% | 11/3/2017 | 11/6/2017 | 11/17/2017 |
| 8/3/2017 | quarterly | $0.15 | 2.82% | 8/10/2017 | 8/14/2017 | 8/24/2017 |
| 4/26/2017 | quarterly | $0.15 | 3.08% | 5/4/2017 | 5/8/2017 | 5/18/2017 |
| 2/6/2017 | Quarterly | $0.15 | 2.89% | 2/14/2017 | 2/16/2017 | 2/27/2017 |
| 10/27/2016 | quarterly | $0.15 | 2.62% | 11/3/2016 | 11/7/2016 | 11/17/2016 |
| 7/27/2016 | quarterly | $0.15 | 3.29% | 8/3/2016 | 8/5/2016 | 8/15/2016 |
| 4/27/2016 | quarterly | $0.15 | 4.15% | 5/4/2016 | 5/6/2016 | 5/18/2016 |
| 2/11/2016 | quarterly | $0.15 | 5.75% | 2/18/2016 | 2/22/2016 | 3/4/2016 |
| 10/29/2015 | quarterly | $0.15 | 6.01% | 11/5/2015 | 11/9/2015 | 11/19/2015 |
| 7/29/2015 | quarterly | $0.15 | 5.12% | 8/5/2015 | 8/7/2015 | 8/18/2015 |
| 4/28/2015 | quarterly | $0.15 | 3.71% | 5/6/2015 | 5/8/2015 | 5/18/2015 |
| 2/11/2015 | quarterly | $0.15 | 3.97% | 2/19/2015 | 2/23/2015 | 3/6/2015 |
| 10/30/2014 | quarterly | $0.15 | 4.17% | 11/6/2014 | 11/10/2014 | 11/20/2014 |
| 10/30/2014 | quarterly | $0.15 | | | 11/20/2014 | 11/10/2014 |
| 7/29/2014 | quarterly | $0.15 | 4.22% | 8/5/2014 | 8/7/2014 | 8/18/2014 |
| 4/29/2014 | quarterly | $0.15 | 3.81% | 5/7/2014 | 5/9/2014 | 5/19/2014 |
| 2/10/2014 | quarterly | $0.15 | 3.8% | 2/19/2014 | 2/21/2014 | 3/7/2014 |
| 10/28/2013 | quarterly | $0.15 | 4.28% | 11/6/2013 | 11/11/2013 | 11/22/2013 |
| 8/5/2013 | quarterly | $0.15 | 4.68% | 8/13/2013 | 8/15/2013 | 8/28/2013 |
| 5/7/2013 | quarterly | $0.15 | 5.34% | 5/15/2013 | 5/17/2013 | 5/30/2013 |
| 2/25/2013 | quarterly | $0.15 | 4.98% | 3/5/2013 | 3/7/2013 | 3/21/2013 |
(Data available from 1/1/2013 forward)
Psychemedics (NASDAQ PMD) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 9.90%
Institutional Ownership Percentage: 55.53%
Psychemedics (NASDAQ PMD) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/14/2017 | Raymond C Kubacki Jr | CEO | Buy | 1,000 | $16.88 | $16,880.00 | 178,228 | |
| 9/6/2017 | Michael I Schaffer | VP | Sell | 7,548 | $20.41 | $154,054.68 | 41,273 | |
| 9/5/2017 | Michael I Schaffer | VP | Sell | 4,400 | $20.37 | $89,628.00 | 41,273 | |
| 9/1/2017 | Michael I Schaffer | VP | Sell | 981 | $21.16 | $20,757.96 | 41,273 | |
| 3/9/2017 | James V Dyke | VP | Sell | 10,513 | $20.56 | $216,147.28 | 17,050 | |
| 12/14/2016 | James V Dyke | VP | Sell | 5,091 | $22.83 | $116,227.53 | 31,024 | |
| 12/9/2016 | Fred J Weinert | Director | Sell | 4,601 | $24.45 | $112,494.45 | 26,983 | |
| 11/18/2016 | Neil Lerner | VP | Sell | 3,000 | $24.75 | $74,250.00 | 25,722 | |
| 11/15/2016 | James V Dyke | VP | Sell | 10,000 | $23.56 | $235,600.00 | 37,654 | |
| 3/2/2016 | Harry F Sr Connick Sr | Director | Buy | 700 | $12.83 | $8,981.00 | 41,362 | |
| 2/26/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $12.63 | $12,630.00 | 40,262 | |
| 2/24/2016 | Harry F Sr Connick Sr | Director | Buy | 2,000 | $12.36 | $24,720.00 | 38,262 | |
| 2/22/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $12.61 | $12,610.00 | 38,262 | |
| 2/19/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $11.95 | $11,950.00 | 37,662 | |
| 2/16/2016 | Michael I Schaffer | VP | Buy | 4,507 | $11.09 | $49,982.63 | 46,472 | |
| 12/2/2015 | David Hodge | Director | Buy | 550,000 | $0.01 | $5,500.00 | | |
| 11/24/2015 | David Hodge | Director | Buy | 260,000 | $0.01 | $2,600.00 | | |
| 9/14/2015 | Raymond C. Kubacki, Jr. | CEO | Buy | 2,000 | $10.12 | $20,240.00 | 185,647 | |
| 9/10/2015 | Neil Lerner | VP | Buy | 3,000 | $10.32 | $30,960.00 | 30,051 | |
| 6/16/2015 | Michael I Schaffer | VP | Sell | 2,837 | $14.62 | $41,476.94 | | |
| 4/8/2015 | David Hodge | Director | Buy | 3,000 | $0.01 | $30.00 | | |
(Data available from 1/1/2013 forward)
Psychemedics (NASDAQ PMD) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Psychemedics: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 10:21 AM |
| Psychemedics Announces 1Q Record Revenues and Dividend Increase of 20%
finance.yahoo.com - April 25 at 10:21 AM |
 | Psychemedics (PMD) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 16 at 3:46 AM |
| Only 3 Days Left To Cash In On Psychemedics Corporation (NASDAQ:PMD) Dividend, Is It Worth Buying?
finance.yahoo.com - March 12 at 9:46 AM |
| Psychemedics Corp. Plans Quarterly Dividend of $0.15 (PMD)
www.americanbankingnews.com - March 11 at 7:52 AM |
 | BRIEF-Psychemedics Corporation Q4 Earnings Per Share $0.42
www.reuters.com - March 8 at 4:34 PM |
| Psychemedics Corporation Announces Q4 and Year End Results
finance.yahoo.com - March 8 at 10:39 AM |
| Psychemedics Corp. (PMD) Shares Bought by Moors & Cabot Inc.
www.americanbankingnews.com - March 5 at 3:44 PM |
| Psychemedics Corp. (PMD) is Tieton Capital Management LLC's 5th Largest Position
www.americanbankingnews.com - February 27 at 4:14 PM |
| Psychemedics (PMD) to Release Earnings on Monday
www.americanbankingnews.com - January 29 at 3:56 AM |
| 6 Cheap Stocks With a High Dividend Yield
finance.yahoo.com - January 3 at 4:46 PM |
| ETFs with exposure to Psychemedics Corp. : November 27, 2017
finance.yahoo.com - November 27 at 4:33 PM |
| Psychemedics Corporation (PMD) CEO Raymond C. Kubacki, Jr. Buys 1,000 Shares
www.americanbankingnews.com - November 15 at 10:20 AM |
| Psychemedics Corp. : PMD-US: Dividend Analysis : November 06th, 2017 (record date) : By the numbers : November 6, 2017
finance.yahoo.com - November 7 at 8:50 AM |
| Psychemedics Corporation (PMD) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - November 4 at 2:10 PM |
| ETFs with exposure to Psychemedics Corp. : October 30, 2017
finance.yahoo.com - October 31 at 8:00 AM |
| Only 3 Days Left Before Psychemedics Corporation (PMD) Will Start Trading Ex-Dividend, Should You Buy?
finance.yahoo.com - October 31 at 8:00 AM |
| Psychemedics Corp. :PMD-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 27 at 10:46 AM |
| Psychemedics Corporation (PMD) Plans Quarterly Dividend of $0.15
www.americanbankingnews.com - October 26 at 9:01 AM |
| Psychemedics Corporation Announces Q3 Earnings
finance.yahoo.com - October 25 at 9:14 AM |
| Psychemedics Corporation (PMD) Announces Earnings Results
www.americanbankingnews.com - October 24 at 8:28 PM |
| Psychemedics Corporation (PMD) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 17 at 5:58 AM |
| Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM |
 | Psychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM |
| Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM |
| Insider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM |
| Michael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM |
| Michael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM |
| ETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM |
| Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM |
| Psychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM |
| Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM |
| Psychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM |
| Psychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM |
| Psychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM |
| Psychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM |
 | Psychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM |
 | Psychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM |
| The Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM |
 | DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM |
 | SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM |
| DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM |
| PSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM |
| PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM |
Psychemedics (NASDAQ:PMD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Psychemedics (NASDAQ:PMD) Income Statement, Balance Sheet and Cash Flow Statement
Psychemedics (NASDAQ PMD) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
